Free Trial Information
BioCentury | Apr 1, 2020
Finance

Reversing course on IPO plans, iTeos draws $125M in private round with crossovers

...Also participating were existing investors MPM Capital, HBM Partners, 6 Dimensions Capital, Curative Ventures, Fund+, VIVES...
Read More
BioCentury | Jul 13, 2019
Product Development

Why Merck is in infectious disease for the long haul

Merck is bucking the trend of its biopharma peers by continuing to invest in and build its infectious disease pipeline. With new regulatory pathways in play and novel funding mechanisms for antibiotics starting to take...
Read More
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...iTeos Therapeutics S.A. $75.0 Series B HBM Partners, 6 Dimensions Capital, Curative Ventures, SFPI-FPIM, Fund+, Vives...
Read More
BioCentury | Nov 19, 2018
Financial News

NASH company Genfit planning U.S. listing

As it prepares for a readout from a Phase III study of its lead candidate to treat non-alcoholic steatohepatitis, French bellwether Genfit S.A. (Euronext:GNFT) intends to conduct a listing on a U.S. exchange. Genfit said...
Read More
BioCentury | Jun 22, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
Read More
BioCentury | Jun 20, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
Read More
BioCentury | Jun 20, 2018
Finance

Iterating iTeos

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
Read More
BioCentury | May 4, 2018
Financial News

A-Mansia raises €16M for the microbiome

...close of a tranched series A round led by Seventure Partners with participation from Fonds Vives...
Read More
BioCentury | Apr 27, 2018
Financial News

Microbiome company A-Mansia secures €16M

...close of a tranched series A round led by Seventure Partners with participation from Fonds Vives...
Read More
BioCentury | Mar 29, 2018
Emerging Company Profile

Strengthening synapses

...Johnson & Johnson Innovation - JJDC Inc., V-BIO Ventures, the Walloon Investment Fund (SRIW) and VIVES...
Read More
Items per page:
1 - 10 of 29
BioCentury | Apr 1, 2020
Finance

Reversing course on IPO plans, iTeos draws $125M in private round with crossovers

...Also participating were existing investors MPM Capital, HBM Partners, 6 Dimensions Capital, Curative Ventures, Fund+, VIVES...
Read More
BioCentury | Jul 13, 2019
Product Development

Why Merck is in infectious disease for the long haul

Merck is bucking the trend of its biopharma peers by continuing to invest in and build its infectious disease pipeline. With new regulatory pathways in play and novel funding mechanisms for antibiotics starting to take...
Read More
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...iTeos Therapeutics S.A. $75.0 Series B HBM Partners, 6 Dimensions Capital, Curative Ventures, SFPI-FPIM, Fund+, Vives...
Read More
BioCentury | Nov 19, 2018
Financial News

NASH company Genfit planning U.S. listing

As it prepares for a readout from a Phase III study of its lead candidate to treat non-alcoholic steatohepatitis, French bellwether Genfit S.A. (Euronext:GNFT) intends to conduct a listing on a U.S. exchange. Genfit said...
Read More
BioCentury | Jun 22, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
Read More
BioCentury | Jun 20, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
Read More
BioCentury | Jun 20, 2018
Finance

Iterating iTeos

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
Read More
BioCentury | May 4, 2018
Financial News

A-Mansia raises €16M for the microbiome

...close of a tranched series A round led by Seventure Partners with participation from Fonds Vives...
Read More
BioCentury | Apr 27, 2018
Financial News

Microbiome company A-Mansia secures €16M

...close of a tranched series A round led by Seventure Partners with participation from Fonds Vives...
Read More
BioCentury | Mar 29, 2018
Emerging Company Profile

Strengthening synapses

...Johnson & Johnson Innovation - JJDC Inc., V-BIO Ventures, the Walloon Investment Fund (SRIW) and VIVES...
Read More
Items per page:
1 - 10 of 29